Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 14 04:00PM ET
8.73
Dollar change
+0.12
Percentage change
1.39
%
IndexRUT P/E- EPS (ttm)-0.58 Insider Own22.47% Shs Outstand154.93M Perf Week8.58%
Market Cap1.35B Forward P/E- EPS next Y-1.00 Insider Trans8.50% Shs Float120.11M Perf Month48.98%
Income-73.74M PEG- EPS next Q-0.29 Inst Own65.24% Short Float4.66% Perf Quarter45.74%
Sales110.50M P/S12.24 EPS this Y-93.00% Inst Trans16.63% Short Ratio4.60 Perf Half Y52.09%
Book/sh-0.03 P/B- EPS next Y3.94% ROA-33.61% Short Interest5.59M Perf Year60.48%
Cash/sh0.99 P/C8.79 EPS next 5Y- ROE-1928.16% 52W Range3.50 - 9.92 Perf YTD72.87%
Dividend Est.- P/FCF- EPS past 5Y36.03% ROI-282.45% 52W High-12.00% Beta-1.12
Dividend TTM- Quick Ratio0.99 Sales past 5Y610.91% Gross Margin92.04% 52W Low149.43% ATR (14)0.56
Dividend Ex-Date- Current Ratio0.99 EPS Y/Y TTM56.96% Oper. Margin-75.74% RSI (14)64.21 Volatility5.83% 8.06%
Employees268 Debt/Eq6.56 Sales Y/Y TTM202.25% Profit Margin-66.73% Recom1.30 Target Price15.70
Option/ShortYes / Yes LT Debt/Eq4.93 EPS Q/Q-27.04% Payout- Rel Volume1.15 Prev Close8.61
Sales Surprise1.23% EPS Surprise-20.54% Sales Q/Q-10.92% EarningsAug 08 BMO Avg Volume1.22M Price8.73
SMA2013.42% SMA5034.39% SMA20052.94% Trades Volume1,393,877 Change1.39%
Date Action Analyst Rating Change Price Target Change
Sep-27-24Resumed JP Morgan Overweight $10 → $13
Sep-19-24Initiated B. Riley Securities Buy $11
Sep-09-24Initiated JP Morgan Overweight $10
May-15-24Initiated Wells Fargo Overweight $11
Dec-19-23Upgrade Leerink Partners Market Perform → Outperform $5 → $12
Jul-05-23Initiated Raymond James Outperform $7
May-24-23Downgrade Jefferies Buy → Hold $7 → $5
Dec-15-20Resumed H.C. Wainwright Buy $20
Oct-23-20Initiated RBC Capital Mkts Sector Perform $13
Dec-31-19Downgrade SVB Leerink Outperform → Mkt Perform $33 → $10
Oct-11-24 11:56AM
09:55AM
Oct-09-24 05:36PM
Oct-03-24 08:15AM
Oct-01-24 09:20AM
08:30AM Loading…
Sep-30-24 08:30AM
Sep-25-24 09:14PM
06:32AM
Sep-24-24 04:01PM
11:19AM
07:30AM
Aug-24-24 01:17AM
Aug-12-24 08:30AM
Aug-08-24 08:45AM
07:47AM
07:30AM Loading…
07:30AM
Aug-01-24 08:30AM
Jun-25-24 07:30AM
07:30AM
Jun-12-24 08:30AM
May-30-24 08:30AM
May-15-24 07:16AM
May-10-24 04:53PM
02:39PM
May-09-24 07:45AM
07:30AM
07:00AM
May-07-24 08:30AM
May-02-24 08:30AM
Apr-30-24 08:30AM
08:30AM Loading…
Apr-23-24 08:30AM
Mar-27-24 08:30AM
Mar-15-24 08:18AM
Mar-07-24 10:47AM
Mar-06-24 12:51PM
07:51AM
07:30AM
Feb-28-24 08:30AM
04:16AM
Feb-27-24 08:30AM
Feb-06-24 01:17PM
Jan-31-24 01:21PM
Jan-08-24 08:00AM
Jan-03-24 08:30AM
Dec-15-23 08:30AM
Dec-07-23 07:00AM
Dec-06-23 04:10PM
04:08PM
Nov-22-23 08:30AM
Nov-11-23 12:09PM
Nov-09-23 08:38AM
07:43AM
07:30AM
Nov-03-23 04:05PM
Sep-29-23 05:47AM
Sep-28-23 04:15PM
Sep-25-23 08:30AM
Sep-06-23 08:30AM
Sep-05-23 07:30AM
Aug-23-23 11:13AM
Aug-17-23 08:44AM
06:40AM
Aug-10-23 12:40PM
Aug-08-23 06:02AM
Aug-04-23 06:45AM
Aug-03-23 08:55AM
07:53AM
07:30AM
Jul-27-23 08:30AM
Jul-06-23 08:40AM
Jun-26-23 08:30AM
Jun-19-23 08:00AM
May-23-23 07:30AM
May-16-23 08:30AM
May-08-23 06:03AM
May-05-23 06:19AM
May-03-23 08:55AM
07:49AM
07:30AM
Apr-26-23 08:30AM
Apr-20-23 08:30AM
Mar-29-23 08:54AM
08:00AM
Mar-24-23 07:36AM
Mar-22-23 08:45AM
07:30AM
Mar-02-23 08:30AM
Feb-14-23 12:00PM
09:35AM
Feb-09-23 04:05PM
Jan-25-23 06:06AM
Jan-13-23 07:26AM
Jan-03-23 05:40AM
Dec-30-22 12:00PM
09:03AM
Dec-19-22 01:04PM
07:37AM
Dec-15-22 09:07AM
06:11AM
Dec-13-22 11:27AM
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moran KyleChief Financial OfficerOct 11 '24Option Exercise2.4825,00062,00044,777Oct 11 08:00 PM
GSK plc10% OwnerSep 27 '24Buy8.002,791,93022,335,44016,775,691Oct 01 05:54 PM
Moran KyleChief Financial OfficerSep 25 '24Sale9.0017,146154,31419,777Sep 27 08:00 PM
KYLE MORANOfficerSep 25 '24Proposed Sale9.0017,146154,314Sep 25 09:40 PM
BOLNO PAULPresident and CEOAug 21 '24Sale5.7848,366279,555359,059Aug 23 06:00 PM
PAUL BOLNOOfficerAug 21 '24Proposed Sale5.7848,366279,638Aug 21 04:24 PM
Vargeese ChandraSee RemarksJul 22 '24Option Exercise2.4868,210169,161185,061Jul 24 05:54 PM
Moran KyleChief Financial OfficerApr 03 '24Sale6.1715,63096,42133,921Apr 05 08:00 PM
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM
RA CAPITAL MANAGEMENT, L.P.DirectorDec 11 '23Buy5.001,000,0005,000,00019,202,009Dec 13 04:33 PM